Outro, which is now available in seven states, wants to help people taper off antidepressants without experiencing debilitating side effects.

Silicon Valley’s coveted work visas are under heavy scrutiny from the Trump administration, and immigration lawyers say requests for documentation are increasing.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.